ID: ALA3753379

Max Phase: Preclinical

Molecular Formula: C9H3BrClN3S2

Molecular Weight: 332.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1cc(Br)ccc1/N=c1\ssnc1Cl

Standard InChI:  InChI=1S/C9H3BrClN3S2/c10-6-1-2-7(5(3-6)4-12)13-9-8(11)14-16-15-9/h1-3H/b13-9-

Standard InChI Key:  FXQXYAMWVMIBBZ-LCYFTJDESA-N

Associated Targets(Human)

Neutral amino acid transporter B(0) 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.63Molecular Weight (Monoisotopic): 330.8640AlogP: 3.72#Rotatable Bonds: 1
Polar Surface Area: 49.04Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.70CX LogD: 4.70
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.75Np Likeness Score: -1.52

References

1. Schulte ML, Khodadadi AB, Cuthbertson ML, Smith JA, Manning HC..  (2016)  2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.,  26  (3): [PMID:26750251] [10.1016/j.bmcl.2015.12.031]

Source